What is the recommended dose of azithromycin (Zithromax) for various infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Azithromycin Dosing Recommendations

For adults with community-acquired pneumonia, the standard regimen is 500 mg on day 1, followed by 250 mg once daily on days 2-5, while for sexually transmitted infections a single 1-2 gram dose is appropriate, and pediatric dosing is weight-based at 10 mg/kg (max 500 mg) on day 1, then 5 mg/kg (max 250 mg) daily for days 2-5. 1

Adult Dosing by Indication

Respiratory Tract Infections

  • Community-acquired pneumonia (mild severity): 500 mg as a single dose on day 1, followed by 250 mg once daily on days 2-5 (total 5-day course) 1, 2
  • Alternative 3-day regimen: 500 mg once daily for 3 consecutive days 1, 2
  • Acute bacterial exacerbations of COPD: Either 500 mg daily for 3 days OR the standard 5-day regimen (500 mg day 1, then 250 mg daily days 2-5) 1
  • Acute bacterial sinusitis: 500 mg once daily for 3 days 1
  • Pharyngitis/tonsillitis (second-line therapy): 500 mg day 1, then 250 mg daily days 2-5 1

Sexually Transmitted Infections

  • Non-gonococcal urethritis and cervicitis: Single 1 gram dose 1
  • Genital ulcer disease (chancroid): Single 1 gram dose 1
  • Gonococcal urethritis and cervicitis: Single 2 gram dose 1

Skin and Soft Tissue Infections

  • Uncomplicated skin/skin structure infections: 500 mg day 1, then 250 mg daily days 2-5 1, 3
  • Alternative studied regimen: 500 mg once daily for 3 days 3

Hospitalized Patients

  • Intravenous azithromycin for admitted patients: 500 mg daily for 2-5 days, followed by oral therapy at 500 mg daily for a total of 7-10 days 2
  • This IV regimen has demonstrated efficacy even in patients with pneumococcal bacteremia 2

Pediatric Dosing (Age ≥6 months)

Standard 5-Day Regimen

  • Community-acquired pneumonia and acute otitis media: 10 mg/kg (maximum 500 mg) as a single dose on day 1, followed by 5 mg/kg (maximum 250 mg) once daily on days 2-5 1, 4
  • This regimen is recommended by both the American Academy of Pediatrics and the Infectious Diseases Society of America 4

Alternative 3-Day Regimen

  • Acute otitis media and acute bacterial sinusitis: 10 mg/kg once daily for 3 consecutive days 1

Single-Dose Regimen

  • Acute otitis media only: 30 mg/kg as a single dose (maximum 1,200 mg) 1
  • If vomiting occurs within 30 minutes, re-dosing at the same total dose has been studied, though safety data are limited 1

Pharyngitis/Tonsillitis (Age ≥2 years)

  • Higher dose required: 12 mg/kg once daily for 5 days 1, 5
  • This higher dose is necessary because standard dosing resulted in more recurrences compared to penicillin 5

Pertussis Treatment and Prophylaxis

  • Infants <6 months: 10 mg/kg once daily for 5 days 4
  • Children ≥6 months: 10 mg/kg (max 500 mg) day 1, then 5 mg/kg (max 250 mg) daily days 2-5 4
  • Azithromycin is preferred over erythromycin in young infants due to better safety profile 4

Intravenous Pediatric Dosing

  • IV azithromycin: 10 mg/kg once daily (maximum 500 mg per dose) on days 1-2, then transition to oral therapy when clinically feasible 4
  • Prolonged IV therapy beyond 2 days should be avoided when oral therapy is tolerated 4

Weight-Based Dosing Table (for 5-day regimen)

  • 5 kg (11 lbs): 2.5 mL day 1, then 1.25 mL days 2-5 (using 100 mg/5 mL suspension) 1
  • 10 kg (22 lbs): 5 mL day 1, then 2.5 mL days 2-5 1
  • 20 kg (44 lbs): 5 mL day 1, then 2.5 mL days 2-5 (using 200 mg/5 mL suspension) 1
  • 30 kg (66 lbs): 7.5 mL day 1, then 3.75 mL days 2-5 1
  • 40 kg (88 lbs): 10 mL day 1, then 5 mL days 2-5 1
  • ≥50 kg (≥110 lbs): 12.5 mL day 1, then 6.25 mL days 2-5 1

Special Populations

Renal Impairment

  • GFR 10-80 mL/min: No dosage adjustment required 1
  • GFR <10 mL/min: Exercise caution as AUC increases by 35%; however, no specific dose adjustment is established 1

Hepatic Impairment

  • Pharmacokinetics have not been established in hepatic impairment 1
  • No dose adjustment recommendations can be made 1

Age and Gender

  • No dosage adjustment required based on age or gender alone 1

Administration Considerations

Food Effects

  • Adults and children: Azithromycin tablets and oral suspension can be taken with or without food 1
  • However, coadministration with a large meal may reduce absorption by up to 50% 6

Drug Interactions

  • Avoid concurrent administration with aluminum- or magnesium-containing antacids as they reduce absorption 4, 1
  • If antacids are necessary, separate administration times 4
  • Monitor when used with drugs metabolized by cytochrome P450 enzyme system 4
  • Monitor for QT interval prolongation when combined with other QT-prolonging medications 4

Clinical Pearls and Common Pitfalls

Atypical Pathogens

  • Azithromycin provides excellent coverage for atypical respiratory pathogens including Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella species 2, 5
  • For severe community-acquired pneumonia, azithromycin should be combined with a beta-lactam active against drug-resistant Streptococcus pneumoniae 2

Tolerance Profile

  • Gastrointestinal adverse effects (nausea, diarrhea, abdominal pain) are the most common but generally mild to moderate 4, 5
  • Azithromycin has better gastrointestinal tolerance than erythromycin 4, 5, 6

Resistance Considerations

  • Azithromycin is active against erythromycin- and penicillin-susceptible S. pneumoniae and methicillin-susceptible S. aureus 5
  • In areas with high rates of resistant S. pneumoniae, consider alternative agents or combination therapy 2

Infantile Hypertrophic Pyloric Stenosis (IHPS)

  • In infants under 1 month, azithromycin has not been associated with IHPS, though monitoring is recommended 4
  • The benefits of treating severe pertussis outweigh potential risks in this age group 4

Pregnancy Classification

  • FDA Pregnancy Category B 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Azithromycin Dosage and Administration Guidelines for Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.